A comparison of tumour size measurements with palpation, ultrasound and mammography in male breast cancer: first results of the prospective register study
ConclusionsOur data demonstrate that MG and US have similar accuracy with regard to tumour size estimation. US assessment showed the highest sensitivity in determining tumour size, followed by MG and CE. However, MG demonstrated a significant advantage for estimating the real tumour size for pT2 tumours compared to US or CE.
Conclusion 18F-FDG PET/CT showed good diagnostic and prognostic utility in recurrent MBC. It was better than bone scan in evaluation of skeletal metastases. Most importantly, 18F-FDG PET/CT helped in early detection of second malignancy and their clinical management in studied patients.
This article summarizes the methodology, results, and challenges of the reconstruction of red bone marrow and male breast doses for a 1,982-person sub-cohort of ∼114,270 U.S. military veterans who participated in eight atmospheric nuclear weapons tests between 1945 and 1962. These doses are being used in an epidemiological investigation of leukemia and male breast cancer as part of a study of one million U.S. persons to investigate risk from chronic low-dose radiation exposure. METHODS: Previous doses to these veterans had been estimated for compensation and tended to be biased high but newly available docum...
ConclusionsPD-1 seems to be less often expressed in male breast cancer compared to female breast cancer. Although PD-1 and PD-L1 are not definite indicators for good or bad responses, male breast cancer patients may therefore respond differently to checkpoint immunotherapy with PD-1 inhibitors than female patients.
Piera Rizzolo, Valentina Silvestri, Agostino Bucalo, Veronica Zelli, Virginia Valentini, Irene Catucci, Ines Zanna, Giovanna Masala, Simonetta Bianchi, Alessandro Mauro Spinelli, Stefania Tommasi, Maria Grazia Tibiletti, Antonio Russo, Liliana Varesco, Anna Coppa, Daniele Calistri, Laura Cortesi, Alessandra Viel, Bernardo Bonanni, Jacopo Azzollini, Siranoush Manoukian, Marco Montagna, Paolo Radice, Domenico Palli, Paolo Peterlongo, Laura Ottini
Response to "Male Patients With Breast Cancer: Addressing Needs Using an Educational Task Force". Clin J Oncol Nurs. 2018 Dec 01;22(6):610 Authors: Mahon SM, Nagtalon Cutrone J, Baron RH Abstract Male breast cancer is associated with hereditary risk for developing breast and other cancers. An estimated 4% of men with breast cancer have BRCA1 mutations, and 4%-16% have BRCA2 mutations. Men with a diagnosis of breast cancer have unique needs that need to be addressed in a caring and comprehensive manner. PMID: 30452015 [PubMed - in process]
ConclusionsCollaborative studies are required so that men can participate in meaningful RCTs to provide an evidence-based rational foundation for the surgery of MBC.
Publication date: November 2018Source: Journal of the American College of Radiology, Volume 15, Issue 11, SupplementAuthor(s): Expert Panel on Breast Imaging:, Bethany L. Niell, Ana P. Lourenco, Linda Moy, Paul Baron, Aarati D. Didwania, Roberta M. diFlorio-Alexander, Samantha L. Heller, Anna I. Holbrook, Huong T. Le-Petross, Alana A. Lewin, Tejas S. Mehta, Priscilla J. Slanetz, Ashley R. Stuckey, Daymen S. Tuscano, Gary A. Ulaner, Nina S. Vincoff, Susan P. Weinstein, Mary S. NewellAbstractAlthough the majority of male breast problems are benign with gynecomastia as the most common etiology, men with breast symptoms and th...
Despite differences in demographic and disease-related characteristics, male breast cancer patients are treated similarly to female patients, with similar outcomes.Medscape Medical News
Male breast cancer? Male breast cancer is rare. It's most common in older men, though it can occur at any age. Men diagnosed with breast cancer at an early stage have a good chance for a cure. Your health care provider will consider the stage of your cancer, and your overall health and preferences when [...]
Dr. Jennifer Ashton discusses what everyone should know about male breast cancer and "GMA" talks to survivors as the new ABC drama "A Million Little Things" shines a light on the disease.